Twist Biosciences CEO Sells Shares Worth $1.1 Million
On May 28, 2026, Twist Biosciences' (TWST) CEO Emily Leproust sold approximately 16,470 shares worth around $1.1 million after exercising stock options. The transaction aligns with her historical selling patterns and does not indicate a significant change in strategy or sentiment.
Tickers: $TWST
Topics: CEO activity insider trading stock options